Development of a Hypoallergenic Recombinant Parvalbumin for First-in-Man Subcutaneous Immunotherapy of Fish Allergy.

Zuidmeer-Jongejan L., Huber H., Swoboda I., Rigby N., Versteeg S. A., Jensen B. M., Quaak S., Akkerdaas J. H., Blom L., Asturias J., Bindslev-Jensen C., Bernardi M. L., Clausen M., Ferrara R., Hauer M., Heyse J., Kopp S., Kowalski M. L., Lewandowska-Polak A., Linhart B., Maderegger B., Maillere B., Mari A., Martinez A., Mills E. N., Neubauer A., Nicoletti C., Papadopoulos N. G., Portoles A.. (2015)

International Archives of Allergy & Immunology, 166, 41-51

The FAST (food allergy-specific immunotherapy) project aims at developing safe and effective subcutaneous immunotherapy for fish allergy, using recombinant hypoallergenic carp parvalbumin, Cyp c 1.

International Archives of Allergy & Immunology, 166, 41-51

View Publication